Related Experiment Video
Updated: Nov 17, 2025
04:20
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
1.2K
TCGA dataset screening for genes implicated in endometrial cancer using RNA-seq profiling
Xiaoli Fu1, Shuai Cheng2, Wei Wang2
1College of Public Health, Zhengzhou University, Zhengzhou 450001, China.
Cancer Genetics
|February 15, 2021
Summary
This study identifies key genes in endometrial cancer (EC) by analyzing gene expression data. AURKA, CENPA, and KIF2C show promise as biomarkers for predicting patient outcomes in EC.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- The molecular mechanisms and potential biomarkers for endometrial cancer (EC) require further investigation.
- Understanding transcriptional changes in EC is crucial for identifying new diagnostic and prognostic tools.
Purpose of the Study:
- To comprehensively characterize transcriptional alterations in endometrial cancer.
- To identify potential molecular biomarkers and therapeutic targets for EC.
Main Methods:
- Utilized RNA-sequencing data from The Cancer Genome Atlas (TCGA) for EC.
- Performed differential gene expression analysis, Gene Ontology, and KEGG pathway enrichment.
- Constructed a protein-protein interaction network to identify hub genes.
Main Results:
- Identified differentially expressed genes (DEGs) between EC tumor and normal tissues.
- Discovered 10 hub genes within the protein-protein interaction network.
- AURKA, CENPA, and KIF2C were identified as significant prognostic biomarkers for EC patients.
Conclusions:
- The identified hub genes, particularly AURKA, CENPA, and KIF2C, hold potential as biomarkers for endometrial cancer.
- This research provides a foundation for future biological and clinical studies in EC.
- Comprehensive transcriptional profiling aids in understanding EC mechanisms and identifying prognostic markers.
